Sunbelt Securities’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY.RT
JCI
BC
TNB
WAM
IAIM
Sunbelt Securities's BMY.RT Position: Q1 2021 in Review
Sunbelt Securities sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 100,296 shares — an estimated $69K sold.
Sunbelt Securities first reported a position in BMY.RT in Q4 2020 and held it in 1 quarter. The position peaked at $69K in Q4 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.
- Sunbelt Securities reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
- Sunbelt Securities sold 100,296 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $69K.
- Sunbelt Securities first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2020 and held it in 1 quarter.
- Sunbelt Securities's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $69K in Q4 2020.
- 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.
Based on Sunbelt Securities's 13F filing for Q1 2021, filed 27 May 2021.